Crossmark

Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines

Crossref DOI link: https://doi.org/10.1186/2053-6844-1-2

Published Online: 2014-09-30

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lopez-Acevedo, Micael

Grace, Lisa

Teoh, Deanna

Whitaker, Regina

Adams, David J

Jia, Jingquan

Nixon, Andrew B

Secord, Angeles Alvarez
More Information

Article History

Received: 22 March 2014

Accepted: 2 July 2014

First Online: 30 September 2014